Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Atherosclerosis: the path from genomics to therapeutics.

Journal of the American College of Cardiology - 17 Apr 2007

Miller David T, Ridker Paul M, Libby Peter, Kwiatkowski David J

Abstract excerpt

Recent rapid advances in genomic tools and techniques hold great promise for transforming the practice of cardiovascular medicine. Resources including the Human Genome Project and the International HapMap project, major technological advances in high-throughput genotyping and methods of statistical analysis, and methods for high-throughput gene expression and small molecule profiling allow researchers to confront...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Atherosclerosis
Share to Cardiac Surgical Procedures
Share to Cardiotonic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Coronary Artery Disease

Share to Genome, Human

Share to Human Genome Project

Share to Proteomics

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 17433948
DOI: 10.1016/j.jacc.2006.12.045

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Atherosclerosis: the path from genomics to therapeutics.PMID 17433948Read ↗

Genetics, genomics and proteomics in atherosclerosis researchSemantic proximity Read ↗

Early identification of cardiovascular risk using genomics and proteomics.Semantic proximity Read ↗

Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group.Semantic proximity Read ↗

Identification of atherosclerosis-modifying genes: pathogenic insights and therapeutic potential.Semantic proximity Read ↗

Genetic and genomic insights into the molecular basis of atherosclerosis.Semantic proximity Read ↗

Coronary Artery Disease Genetics Enlightened by Genome-Wide Association StudiesSemantic proximity Read ↗

Genetics and Genomics of Coronary Artery Disease.Semantic proximity Read ↗

Genomics of cardiovascular disease.Semantic proximity Read ↗

Clinical Lipidology and the Prevention of Vascular Disease: Time for Personalized Therapy.Semantic proximity Read ↗

Genetics of atherosclerosis.Semantic proximity Read ↗

Genetics of Cardiovascular Disease: How Far Are We from Personalized CVD Risk Prediction and Management?Semantic proximity Read ↗

Predict, prevent and personalize: Genomic and proteomic approaches to cardiovascular medicine.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.